Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Most read article(s)

  • In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
    Open Access
    In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
    Carsten Theodor Beuckmann, Michiyuki Suzuki, Takashi Ueno, Kazuya Nagaoka, Tohru Arai and Hiroyuki Higashiyama
    Journal of Pharmacology and Experimental Therapeutics August 2017, 362 (2) 287-295; DOI: https://doi.org/10.1124/jpet.117.241422
  • You have access
    Anisodamine enhances macrophage M2 polarization through suppressing G9a-mediated IRF4 silencing to alleviate LPS-induced acute lung injury
    Yunfeng Zhang, Dingli Song, Ziyang Peng, Rui Wang, Kai Li, Hong Ren, Xin Sun, Ning Du and Shou-Ching Tang
    Journal of Pharmacology and Experimental Therapeutics April 5, 2022, JPET-AR-2021-001019; DOI: https://doi.org/10.1124/jpet.121.001019
  • Distribution and Function of Prostaglandin E<sub>2</sub> Receptors in Mouse Uterus: Translational Value for Human Reproduction
    Open Access
    Distribution and Function of Prostaglandin E2 Receptors in Mouse Uterus: Translational Value for Human Reproduction
    Deborah P. Fischer, Anna L. Griffiths, Sylvia Lui, Uzmah J. Sabar, Diane Farrar, Peter J. O’Donovan, David F. Woodward and Kay M. Marshall
    Journal of Pharmacology and Experimental Therapeutics June 2020, 373 (3) 381-390; DOI: https://doi.org/10.1124/jpet.119.263509
  • You have access
    TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias
    Vibeke Miller Breinholt, Caroline E. Rasmussen, Per Holse Mygind, Mads Kjelgaard-Hansen, Frank Faltinger, Ana Bernhard, Joachim Zettler and Ulrich Hersel
    Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 459-471; DOI: https://doi.org/10.1124/jpet.119.258251
  • You have access
    A Message from the New Editor-in-Chief
    Beverley Greenwood-Van Meerveld
    Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 92-93; DOI: https://doi.org/10.1124/jpet.121.000984
  • Open Access
    Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib
    Melissa Hopper, Tarikere Gururaja, Taisei Kinoshita, James P. Dean, Ronald J. Hill and Ann Mongan
    Journal of Pharmacology and Experimental Therapeutics March 2020, 372 (3) 331-338; DOI: https://doi.org/10.1124/jpet.119.262063
  • Open Access
    Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
    Michelle G. Baladi, Michael J. Forster, Michael B. Gatch, Richard B. Mailman, Danielle L. Hyman, Lawrence P. Carter and Aaron Janowsky
    Journal of Pharmacology and Experimental Therapeutics August 2018, 366 (2) 367-376; DOI: https://doi.org/10.1124/jpet.118.248120
  • You have access
    Microneedle Coating Methods: A Review with a Perspective
    Rohan S.J. Ingrole and Harvinder Singh Gill
    Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 555-569; DOI: https://doi.org/10.1124/jpet.119.258707
  • You have access
    The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19
    Ali Ehsan Sifat, Saeideh Nozohouri, Heidi Villalba, Bhuvaneshwar Vaidya and Thomas J. Abbruscato
    Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 498-509; DOI: https://doi.org/10.1124/jpet.120.000170
  • SAR340835, a Novel Selective Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure
    Open Access
    SAR340835, a Novel Selective Na+/Ca2+ Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure
    Michel Pelat, Fabrice Barbe, Cyril Daveu, Laetitia Ly-Nguyen, Thomas Lartigue, Suzanne Marque, Georges Tavares, Véronique Ballet, Jean-Michel Guillon, Klaus Steinmeyer, Klaus Wirth, Heinz Gögelein, Petra Arndt, Nils Rackelmann, John Weston, Patrice Bellevergue, Gary McCort, Marc Trellu, Laurence Lucats, Philippe Beauverger, Marie-Pierre Pruniaux-Harnist, Philip Janiak and Frédérique Chézalviel-Guilbert
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 293-304; DOI: https://doi.org/10.1124/jpet.120.000238

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics